NCT03527719 · ACTIVE NOT RECRUITING

China Rural Hypertension Control Project

This trial tests whether village doctors in rural China can lower blood pressure with a multifaceted, intensive program. Researchers track blood pressure control, then heart disease risk, then dementia over four years. It is not a drug test, and no phase applies. It studies a care approach, and results are not yet known.

Eligibility criteria

Eligibility criteria for study villages:
* The village has a regular village doctor who is willing to participate in the hypertension control project
* The village does not plan to merge with other villages within 3 years
* The village is at least 2 kilometers away from other participating villages
* The village participates in the China New Rural Cooperative Medical Scheme
Eligibility criteria of study participants:
* Men or women aged ≥40 years
* Mean untreated systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg or mean treated systolic BP ≥130 mm Hg and/or diastolic BP ≥80 mm Hg for individuals without a history of clinical CVD; or mean treated/untreated systolic BP ≥130 mm Hg and/or diastolic BP ≥80 mm Hg for individuals with a history of clinical coronary heart disease, heart failure, stroke, diabetes, or chronic kidney disease
* Have lived in a participating village for at least 6 months
* No intention to migrate within next 3 years
* Taking part in the New Rural Cooperative Medical Scheme
* Not pregnant or planning to become pregnant
* No malignant tumors and life expectancy ≥3 years
* Willing to participate and able to sign informed consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-12-18

View full record on ClinicalTrials.gov

All APOE4 clinical trials